Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
1.350
-0.020 (-1.46%)
Feb 21, 2025, 4:00 PM EST - Market closed
Aytu BioPharma Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Aytu BioPharma.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Aytu BioPharma.
Recommendation Trends
| Rating | Mar '23 | Apr '23 | May '23 | Jun '23 | Jul '23 | Aug '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +270.37% | Aug 9, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +1,381.48% | May 31, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $220 → $120 | Strong Buy | Maintains | $220 → $120 | +8,788.89% | Jul 21, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $220 → $100 | Buy | Maintains | $220 → $100 | +7,307.41% | May 17, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $480 → $220 | Strong Buy | Maintains | $480 → $220 | +16,196.30% | Apr 28, 2022 |
Financial Forecast
Revenue This Year
71.75M
from 81.00M
Decreased by -11.42%
Revenue Next Year
71.00M
from 71.75M
Decreased by -1.05%
EPS This Year
0.61
from -2.86
EPS Next Year
1.40
from 0.61
Increased by 128.33%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 73.9M | 73.1M | 72.8M | ||
| Avg | 71.8M | 71.0M | 70.7M | ||
| Low | 68.9M | 68.2M | 67.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -8.8% | 1.9% | 2.5% | ||
| Avg | -11.4% | -1.1% | -0.4% | ||
| Low | -14.9% | -4.9% | -4.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.63 | 1.44 | 1.46 |
| Avg | 0.61 | 1.40 | 1.42 |
| Low | 0.59 | 1.34 | 1.36 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 135.0% | 4.4% |
| Avg | - | 128.3% | 1.5% |
| Low | - | 119.4% | -2.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.